Assessment of Systemic Corticosteroid Use in Individuals with Atopic Dermatitis: Findings from a US Population Study

• by Christopher G. Bunick, Ruth Ann Vleugels, Mark Lebwohl, April W. Armstrong, Ayman Grada, Emma Xiaomeng Yue, Madhi Saranadasa, Lani Wegrzyn, Elvira D’Andrea

• February 22, 2026

Daily Itch Duration Linked to Quality-of-Life Burden

Daily itch duration emerged as the strongest factor linking disease severity with quality of life, ahead of sleep disturbance, scratching frequency, and average itch intensity.

• by Andrea Surnit

• July 30, 2026

• 3 min

Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes

• by Caroline Lamarre, Jeffrey Chivinski, Alexandre Hudon

• June 10, 2026

Amendment: Dupilumab Alleviates Itching in Various Dermatological Conditions: Insights from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria

• by Gil Yosipovitch, Brian S. Kim, John Y. Koo, Zhen Chen, Simmi Wiggins, Joseph Zahn, Philip Sugerman, El-Bdaoui Haddad, Sonya L. Cyr

• March 18, 2026